Amicus Jumps to Seven-Year High After $225 Million Share Sale

Shares of Amicus Therapeutics Inc. rose to the highest price in almost seven years after the company raised $225 million in gross proceeds from a share sale.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.